3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine has been researched along with Geographic Atrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ambati, J; Ambati, K; Ambati, M; Ambati, VL; Apicella, I; Baker, KL; Gelfand, BD; Marion, KM; Narendran, S; Pereira, F; Sadda, SR; Varshney, A; Wang, SB; Yerramothu, P | 1 |
1 other study(ies) available for 3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and Geographic Atrophy
Article | Year |
---|---|
A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration.
Topics: Animals; Blotting, Western; Caspase 1; Choroidal Neovascularization; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Geographic Atrophy; Interleukin-1beta; Intravitreal Injections; Macrophages; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Retinal Pigment Epithelium; Reverse Transcriptase Inhibitors; Zidovudine; Zonula Occludens-1 Protein | 2020 |